David M. Spencer

10.1k citations
133 papers · 8.2k indexed · 3 hit papers · h-index 49
Topics
CAR-T cell therapy research (38 papers)Immunotherapy and Immune Responses (27 papers)Immune Cell Function and Interaction (19 papers)

In The Last Decade

David M. Spencer

128 papers receiving 8.0k citations

Hit Papers

Inducible Apoptosis as a Safety Switch...19932026200420152011199320052505007501000

Peers

David M. Spencer
Comparison fields: 5 of 142
  • Molecular Biology 4.7k
  • Oncology 3.5k
  • Immunology 2.2k
  • Genetics 1.7k
  • Biomedical Engineering 904
Replace Ian Rosewell with:
Ian Rosewell United Kingdom
Sheila A. Stewart United States
Timothy P. Fleming United States
Franklin Peale United States
Robert P. Wersto United States
Elio F. Vanin United States
Tan A. Ince United States
Paolo Vezzoni Italy
Joerg Huelsken Switzerland
Gerhard Moldenhauer Germany
David M. Spencer relative to Ian Rosewell United Kingdom Ian Rosewell's profile →
Citations per field
00.5×8.5×
Ian Rosewell · 1×
Citations per year

Countries citing papers authored by David M. Spencer

Since Specialization
Citations

This map shows the geographic impact of David M. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Spencer more than expected).

Fields of papers citing papers by David M. Spencer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Spencer. The network helps show where David M. Spencer may publish in the future.

Co-authorship network of co-authors of David M. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Spencer. A scholar is included among the top collaborators of David M. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Spencer. David M. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 14
3 6
4 144
5 1
6 3
7 18
8 9
9 35
10 48
11 130
12 50
13 19
14 38
15 22
16 15
17 12
18 55
19
Conditional activation of fibroblast growth factor receptor (FGFR) 1, but not FGFR2, in prostate cancer cells leads to increased osteopontin induction, extracellular signal-regulated kinase activation, and in vivo proliferation.
68
20 94

About David M. Spencer

David M. Spencer is a scholar working on Immunology, Oncology and Molecular Biology, having authored 133 papers that have together received 8.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (38 papers), Immunotherapy and Immune Responses (27 papers) and Immune Cell Function and Interaction (19 papers). The work is most often cited by research in Oncology (3.5k citations), Immunology (2.2k citations) and Molecular Biology (4.7k citations). David M. Spencer has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Stuart L. Schreiber, Gerald R. Crabtree, Thomas J. Wandless, Gianpietro Dotti, Cliona M. Rooney, Helen E. Heslop, Malcolm K. Brenner, Kevin W. Freeman, Karin Straathof and Michael Ittmann. Their work appears in journals such as Nature, Science and New England Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026